BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32929957)

  • 21. Design of biomaterials for intracellular delivery of carbon monoxide.
    Inaba H; Fujita K; Ueno T
    Biomater Sci; 2015 Nov; 3(11):1423-38. PubMed ID: 26252321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon-monoxide-releasing molecules for the delivery of therapeutic CO in vivo.
    García-Gallego S; Bernardes GJ
    Angew Chem Int Ed Engl; 2014 Sep; 53(37):9712-21. PubMed ID: 25070185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
    Nobre LS; Jeremias H; Romão CC; Saraiva LM
    Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respiration.
    Jesse HE; Nye TL; McLean S; Green J; Mann BE; Poole RK
    Biochim Biophys Acta; 2013 Sep; 1834(9):1693-703. PubMed ID: 23624261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms.
    Toscani A; Hind C; Clifford M; Kim SH; Gucic A; Woolley C; Saeed N; Rahman KM; Sutton JM; Castagnolo D
    Eur J Med Chem; 2021 Mar; 213():113172. PubMed ID: 33516984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs).
    Choi HI; Zeb A; Kim MS; Rana I; Khan N; Qureshi OS; Lim CW; Park JS; Gao Z; Maeng HJ; Kim JK
    J Control Release; 2022 Oct; 350():652-667. PubMed ID: 36063960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli.
    Wilson JL; Wareham LK; McLean S; Begg R; Greaves S; Mann BE; Sanguinetti G; Poole RK
    Antioxid Redox Signal; 2015 Jul; 23(2):148-62. PubMed ID: 25811604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses, structures, and properties of new manganese carbonyls as photoactive CO-releasing molecules: design strategies that lead to CO photolability in the visible region.
    Gonzalez MA; Carrington SJ; Fry NL; Martinez JL; Mascharak PK
    Inorg Chem; 2012 Nov; 51(21):11930-40. PubMed ID: 23088740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
    Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon monoxide and its donors - Chemical and biological properties.
    Adach W; Błaszczyk M; Olas B
    Chem Biol Interact; 2020 Feb; 318():108973. PubMed ID: 32035862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ruthenium imidazole oxime carbonyls and their activities as CO-releasing molecules.
    Oresmaa L; Tarvainen H; Kolari K; Haukka M
    Dalton Trans; 2012 Aug; 41(36):11170-11175. PubMed ID: 22868452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.
    Qureshi OS; Zeb A; Akram M; Kim MS; Kang JH; Kim HS; Majid A; Han I; Chang SY; Bae ON; Kim JK
    Eur J Pharm Biopharm; 2016 Nov; 108():187-195. PubMed ID: 27634645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CO Sense and Release Flavonols: Progress toward the Development of an Analyte Replacement PhotoCORM for Use in Living Cells.
    Popova M; Soboleva T; Benninghoff AD; Berreau LM
    ACS Omega; 2020 May; 5(17):10021-10033. PubMed ID: 32391490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal-based carbon monoxide releasing molecules with promising cytotoxic properties.
    Mansour AM; Khaled RM; Ferraro G; Shehab OR; Merlino A
    Dalton Trans; 2024 Jun; 53(23):9612-9656. PubMed ID: 38808485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial Activity of the Manganese Photoactivated Carbon Monoxide-Releasing Molecule [Mn(CO)3(tpa-κ(3)N)](+) Against a Pathogenic Escherichia coli that Causes Urinary Infections.
    Tinajero-Trejo M; Rana N; Nagel C; Jesse HE; Smith TW; Wareham LK; Hippler M; Schatzschneider U; Poole RK
    Antioxid Redox Signal; 2016 May; 24(14):765-80. PubMed ID: 26842766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ru(CO)3Cl(Glycinate) (CORM-3): a carbon monoxide-releasing molecule with broad-spectrum antimicrobial and photosensitive activities against respiration and cation transport in Escherichia coli.
    Wilson JL; Jesse HE; Hughes B; Lund V; Naylor K; Davidge KS; Cook GM; Mann BE; Poole RK
    Antioxid Redox Signal; 2013 Aug; 19(5):497-509. PubMed ID: 23186316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sense and Release: A Thiol-Responsive Flavonol-Based Photonically Driven Carbon Monoxide-Releasing Molecule That Operates via a Multiple-Input AND Logic Gate.
    Lazarus LS; Esquer HJ; Benninghoff AD; Berreau LM
    J Am Chem Soc; 2017 Jul; 139(28):9435-9438. PubMed ID: 28677975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin.
    Aki T; Unuma K; Noritake K; Kurahashi H; Funakoshi T; Uemura K
    Toxicol In Vitro; 2018 Aug; 50():201-209. PubMed ID: 29580987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs).
    Schatzschneider U
    Br J Pharmacol; 2015 Mar; 172(6):1638-50. PubMed ID: 24628281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
    Sawle P; Foresti R; Mann BE; Johnson TR; Green CJ; Motterlini R
    Br J Pharmacol; 2005 Jul; 145(6):800-10. PubMed ID: 15880142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.